我的生活+的主要目标之一是帮助人们预防新的HIV和其他STI,丙型肝炎和结核病病历的产生。

该应用程序有助于建立医生和HIV感染者之间的匿名沟通。 它可以让您创建简单易行的服药时间表,并设置隐藏和个性化的提醒。

返回
19 十二月 2017, 10:20
4015

FDA Approved The New HIV Test

FDA Approved The New HIV Test - 图片 1

In vitro diagnostics company, Ortho Clinical Diagnostics, announced today that the US Food and Drug Administration has approved their VITROS Immunodiagnostic Products HIV Combo Reagent Pack. According to a press release from Ortho, the Vitros HIV Combo test is a fourth-generation test that can detect both HIV-1 and HIV-2 antibodies (Ab) and the p24 antigen (Ag). This enables the test to detect HIV-1 acute infection earlier than the previous third-generation test.

According to a Centers for Disease Control and Prevention (CDC) Vital Signs report, released November 28, 2017, roughly half of those with the disease have been positive for an average of 3 years before they are diagnosed, and about 15% of those with HIV in the United States don’t know they have the disease. An early diagnosis is crucial so that an infected individual can start life-saving antiretroviral therapy. According to Robert Yates, Ortho's chief operating officer, “With the launch of the VITROS HIV Combo test, laboratories can help provide earlier detection of HIV."

Three external testing laboratories throughout the United States confirmed that the VITROS test, “provides competitive sensitivity and specificity when compared to a leading commercially available fourth-generation test,” according to the press release. Indeed, comparison studies revealed that, “The VITROS HIV Combo test showed earlier detection of acute HIV infection.”

作者: Olga Moiseeva

在社交媒体上分享